Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (1021-1030 of 1,202) with videos related to

Pageof 121
Sort By:
Mbio|February 20, 2014
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteriaIrina A Rodionova, Brian M Schuster, Kristine M Guinn, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
A novel antimycobacterial compound acts as an intracellular iron chelatorMarte S Dragset, Giovanna Poce, Salvatore Alfonso, et al.
The New Phytologist|June 14, 2017
Epistasis × environment interactions among Arabidopsis thaliana glucosinolate genes impact complex traits and fitness in the fieldRachel E Kerwin, Julie Feusier, Alise Muok, et al.
Cell Host & Microbe|February 19, 2013
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skinHeather D Hickman, Glennys V Reynoso, Barbara F Ngudiankama, et al.
Nature Structural & Molecular Biology|February 16, 2016
7SK-BAF axis controls pervasive transcription at enhancersRyan A Flynn, Brian T Do, Adam J Rubin, et al.
The American Review of Respiratory Disease|December 1, 1989
The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary HypertensionE K Weir, L J Rubin, S M Ayres, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Chest|September 25, 2008
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalitiesMichael D McGoon, Adaani E Frost, Ronald J Oudiz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 28, 2018
THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGERoma Y Gianchandani, Francisco J Pasquel, Daniel J Rubin, et al.
The Journal of Biological Chemistry|March 12, 2015
Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial ActivityTatos Akopian, Olga Kandror, Christopher Tsu, et al.
Pageof 121

Showing results (1021-1030 of 1,202) with videos related to

Sort By:
Pageof 121
Mbio|February 20, 2014
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteriaIrina A Rodionova, Brian M Schuster, Kristine M Guinn, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
A novel antimycobacterial compound acts as an intracellular iron chelatorMarte S Dragset, Giovanna Poce, Salvatore Alfonso, et al.
The New Phytologist|June 14, 2017
Epistasis × environment interactions among Arabidopsis thaliana glucosinolate genes impact complex traits and fitness in the fieldRachel E Kerwin, Julie Feusier, Alise Muok, et al.
Cell Host & Microbe|February 19, 2013
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skinHeather D Hickman, Glennys V Reynoso, Barbara F Ngudiankama, et al.
Nature Structural & Molecular Biology|February 16, 2016
7SK-BAF axis controls pervasive transcription at enhancersRyan A Flynn, Brian T Do, Adam J Rubin, et al.
The American Review of Respiratory Disease|December 1, 1989
The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary HypertensionE K Weir, L J Rubin, S M Ayres, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Chest|September 25, 2008
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalitiesMichael D McGoon, Adaani E Frost, Ronald J Oudiz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 28, 2018
THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGERoma Y Gianchandani, Francisco J Pasquel, Daniel J Rubin, et al.
The Journal of Biological Chemistry|March 12, 2015
Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial ActivityTatos Akopian, Olga Kandror, Christopher Tsu, et al.
Pageof 121